Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Motor Units00:46

Motor Units

A motor unit consists of two main components: a single efferent motor neuron (i.e., a neuron that carries impulses away from the central nervous system) and all of the muscle fibers it innervates. The motor neuron may innervate multiple muscle fibers, which are single cells, but only one motor neuron innervates a single muscle fiber.
Motor Units01:13

Motor Units

The motor unit is a fundamental component of the neuromuscular system and plays a crucial role in coordinating muscle contractions. It consists of a somatic motor neuron, which connects and controls multiple skeletal muscle fibers, forming a single functional segment. The axon of the motor neuron branches out and establishes synaptic connections known as neuromuscular junctions with individual muscle fibers within the motor unit.
Motor units come in different sizes, with smaller units...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Austin Sumner 1938-2025.

Neurology·2026
Same author

Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].

Journal of the neurological sciences·2026
Same author

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.

Journal of the neurological sciences·2026
Same author

Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.

Therapeutic advances in neurological disorders·2026
Same author

Expanding the Clinical and Molecular Spectrum of <i>TUBB2B</i> Through Distinct Variants Identified Across Multiple Families.

medRxiv : the preprint server for health sciences·2026
Same author

CEP76 impairment at the centrosome-cilium interface contributes to a spectrum of ciliopathies.

Science advances·2025

Related Experiment Video

Updated: May 9, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

Multifocal motor neuropathy.

Ximena Arcila-Londono1, Richard A Lewis

  • 1Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.

Handbook of Clinical Neurology
|August 13, 2013
PubMed
Summary

Multifocal motor neuropathy causes progressive nerve damage through persistent conduction blocks. Immune mechanisms are implicated, and treatment with intravenous immunoglobulin is effective for this rare disorder.

Keywords:
Conduction blockantibodiesgangliosidesimmunoglobulinmotor neuropathymultifocal

More Related Videos

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Related Experiment Videos

Last Updated: May 9, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Area of Science:

  • Neurology
  • Immunology
  • Peripheral Nerve Biology

Background:

  • Multifocal motor neuropathy (MMN) is a rare autoimmune disorder.
  • It is characterized by persistent conduction block lesions leading to progressive axonal loss.
  • The exact pathogenesis remains incompletely understood.

Purpose of the Study:

  • To summarize the current understanding of multifocal motor neuropathy.
  • To highlight the role of immune mechanisms in MMN pathogenesis.
  • To underscore the clinical and biological significance of MMN research.

Main Methods:

  • Review of existing literature on MMN.
  • Analysis of clinical and pathological findings in MMN patients.
  • Discussion of immune-mediated mechanisms.

Main Results:

  • MMN presents with conduction block lesions causing motor deficits.
  • Axonal loss is a progressive feature of the neuropathy.
  • Intravenous immunoglobulin (IVIg) has demonstrated established efficacy.

Conclusions:

  • MMN pathogenesis involves immune system dysfunction.
  • Understanding MMN offers insights into broader peripheral nerve diseases.
  • Further research is crucial for advancing MMN diagnosis and treatment.